The reassessment of Leqembi’s safety data follows the agency’s previous recommendation of the drug for use in the EU.

The European medicines regulator said on Friday it will review safety information for Eisai and Biogen's Leqembi, nearly ...

Marketing authorization for the first EU vaccine to protect adolescents against chikungunya has been expedited for its public ...

The EU executive is expected to push ahead with an extremely streamlined timeline for a key piece of health legislation, ...